Petar Ozretić

Dr. Petar Ozretić

Rudjer Boskovic Institute, Zagreb, Zagreb, Grad, Croatia
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2022 in Trends in Ecology & Evolution
Verified
Journal Article
Open access
GFGiulio Formenti
Giulio Formenti
KTKathrin Theissinger
Kathrin Theissinger
CFCarlos Fernandes
Carlos Fernandes
IBIliana Bista
Iliana Bista
ABAureliano Bombarely
Aureliano Bombarely
GZGabrielle Zammit
Gabrielle Zammit
Progress in genome sequencing now enables the large-scale generation of reference genomes. Various international initiatives aim to generate reference genomes representing global biodiversity. These genomes provide unique insights into genomic diversity and architecture, thereby enabling comprehensive analyses of population and functional genomics, and are expected to revolutionize conservation genomics.

Verified
Journal Article
Open access
PDF file
Maja SabolMaja Sabol
Maja Sabol
DTDiana Trnski
Diana Trnski
VMVesna Musani
Vesna Musani
Petar OzretićPetar Ozretić
Petar Ozretić
SLSonja Levanat
Sonja Levanat
GLI transcription factors have important roles in intracellular signaling cascade, acting as the main mediators of the HH-GLI signaling pathway. This is one of the major developmental pathways, regulated both canonically and non-canonically. Deregulation of the pathway during development leads to a number of developmental malformations, depending on the deregulated pathway component. The HH-GLI pathway is mostly inactive in the adult organism but retains its function in stem cells. Aberrant activation in adult cells leads to carcinogenesis through overactivation of several tightly regulated cellular processes such as proliferation, angiogenesis, EMT. Targeting GLI transcription factors has recently become a major focus of potential therapeutic protocols.

30 May 2023 in Life
Verified
Journal Article
Open access
PDF file
DĆDiana Ćesić
Diana Ćesić
Liborija Lugović-MihićLiborija Lugović-Mihić
Liborija Lugović-Mihić
Petar OzretićPetar Ozretić
Petar Ozretić
ILIvana Lojkić
Ivana Lojkić
MBMarija Buljan
Marija Buljan
ATArjana Tambic
Arjana Tambic
(1) Background: Chronic spontaneous urticaria (CSU) has been linked to the dysbiosis of the gut microbiota. Furthermore, various studies have highlighted the anti-inflammatory properties of short-chain fatty acids (SCFAs), whose production is primarily regulated by the gut microbiota. However, only a few studies have investigated the role of major SCFA producers, such as Lachnospiraceae, in skin inflammatory diseases. (2) Goal: This study aimed to compare the abundance of Lachnospiraceae between CSU patients and healthy controls (HCs). (3) Material and methods: In this case–control study, 16S rRNA sequencing was performed to compare the composition of the gut microbiome between 22 CSU patients and 23 HCs. (4) Results: Beta-diversity revealed significant clustering (p < 0.05) between the CSU patients and HCs. Alpha diversity in the CSU group was significantly decreased according to the Evenness index (p < 0.05). The linear discriminant analysis effect size (LEfSe) identified the significant depletion of the Lachnospiraceae family in CSU patients. (5) Conclusion: Our study revealed the dysbiosis of the gut microbiota in CSU patients, including decreased levels of Lachnospiraceae members, responsible for SCFA production, suggesting that SCFAs may contribute to immune dysfunction in the pathogenesis of CSU. We speculate that the modulation of SCFAs could serve as a prospective additional option in CSU treatment.

1 December 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
DTDiana Trnski
Diana Trnski
Maja SabolMaja Sabol
Maja Sabol
AGAnte Gojević
Ante Gojević
MMMarina Martinić
Marina Martinić
Petar OzretićPetar Ozretić
Petar Ozretić
SLSonja Levanat
Sonja Levanat

27 July 2017 in The International Journal of Biological Markers
Verified
Journal Article
Closed access
Petar OzretićPetar Ozretić
Petar Ozretić
IAIlija Alvir
Ilija Alvir
BSBozena Sarcevic
Bozena Sarcevic
ZVZeljko Vujaskovic
Zeljko Vujaskovic
ZRZrinka Rendic-Miocevic
Zrinka Rendic-Miocevic
LBLidija Beketić-Orešković
Lidija Beketić-Orešković
Background: The objective of this study was to examine the prognostic significance of carbonic anhydrase IX (CAIX), an endogenous marker for tumor hypoxia; the cellular tumor antigen p53; and the apoptosis regulator Bcl-2, in triple-negative breast cancer (TNBC) patients. Methods: Immunohistochemically determined expression of CAIX, p53, Bcl-2 and proliferation factor Ki-67, analyzed in 64 paraffin-embedded TNBC tissue samples, was used to assess their relation to clinicopathological variables and prognostic implications for overall survival (OS). Results: Bcl-2 expression was negatively correlated with histological grade of tumor, while expression of p53 was positively correlated with the same clinical variable (p = 0.036 and p = 0.033, respectively). The p53 expression was also positively correlated with tumor size (p = 0.010). Survival analysis showed that patients with high Bcl-2 expression (above cutoff value determined by receiver operator characteristic [ROC] curve analysis) had shorter OS (p = 0.020). The same was observed for patients with tumors larger than 5 cm (p = 0.034) or positive lymph nodes (p = 0.004). Among all 3 examined markers, multivariate analysis showed that only Bcl-2 expression was a strong independent prognostic indicator for decreased OS (hazard ratio [HR] = 15.16, 95% confidence interval [95% CI], 2.881-79.727, p = 0.001). Conclusions: Elevated expression of Bcl-2 was an independent prognostic factor for poorer OS in TNBC and as such a significant marker for tumor aggressiveness.

1 March 2011
Verified
Journal Article
Closed access
PMPetra Marić
Petra Marić
Petar OzretićPetar Ozretić
Petar Ozretić
SLSonja Levanat
Sonja Levanat
SOSlavko Oresković
Slavko Oresković
KAKatarina Antunac
Katarina Antunac
LBLidija Beketić-Oresković
Lidija Beketić-Oresković